Offer - Urjas Oil for just ₹ 1 X
Espazine 5 Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of Schizophrenia. Secondary and off-label uses of Espazine 5 Tablet have also been mentioned below.
The correct dosage of Espazine 5 Tablet depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Some other side effects of Espazine 5 Tablet have been listed ahead. Such side effects of Espazine 5 Tablet normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Espazine 5 Tablet's effect during pregnancy is Moderate and Severe while nursing. It is important to know if Espazine 5 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Espazine 5 Tablet related warnings section.
Espazine 5 Tablet is contraindicated in people with pre-existing medical conditions like Depression, Heart Failure, Dementia as it can result in adverse effects. Some other conditions that can be affected by Espazine 5 Tablet are listed in the contraindications section below.
Besides this, Espazine 5 Tablet may also have severe interaction with some medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Espazine 5 Tablet is not safe while driving, and is is not addictive in nature.
Espazine 5 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Espazine 5 Tablet safe for pregnant women?
Espazine can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Espazine right away. Take your doctor's advice before taking it again.
Is the use of Espazine 5 Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Espazine. So it is adviced to consult the doctor before using it.
What is the effect of Espazine 5 Tablet on the Kidneys?
No research work has been carried out till date on effects of Espazine on kidney. So it is not known whether taking Espazine will cause side effects on kidney or not.
What is the effect of Espazine 5 Tablet on the Liver?
There is no research available on the side effects of Espazine on the liver. Therefore, its impact is unknown.
What is the effect of Espazine 5 Tablet on the Heart?
Side effects of Espazine rarely affect the heart.
Espazine 5 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Espazine 5 Tablet unless your doctor advises you to do so -
Is this Espazine 5 Tablet habit forming or addictive?
Espazine 5 Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Espazine 5 Tablet as you may feel sleepy.
Is it safe?
Espazine 5 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
Yes, Espazine 5 Tablet is useful in treating mental disorders.
Interaction between Food and Espazine 5 Tablet
Taking Espazine 5 Tablet with food is safe.
Interaction between Alcohol and Espazine 5 Tablet
Taking Espazine 5 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 439-440